Cerium oxide nanoparticles inhibit oxidative stress and nuclear factor-κB activation in H9c2 cardiomyocytes exposed to cigarette smoke extract. - Wikidata - awgldk - TriplyDB

Cerium oxide nanoparticles inhibit oxidative stress and nuclear factor-κB activation in H9c2 cardiomyocytes exposed to cigarette smoke extract.

Cerium oxide nanoparticles inhibit oxidative stress and nuclear factor-κB activation in H9c2 cardiomyocytes exposed to cigarette smoke extract.

http://www.wikidata.org/entity/Q35077951

about

Cerium oxide nanoparticles attenuate monocrotaline induced right ventricular hypertrophy following pulmonary arterial hypertension The yin: an adverse health perspective of nanoceria: uptake, distribution, accumulation, and mechanisms of its toxicity Inhibition of MAP kinase/NF-kB mediated signaling and attenuation of lipopolysaccharide induced severe sepsis by cerium oxide nanoparticles Antioxidant Cerium Oxide Nanoparticles in Biology and Medicine Catalytic Properties and Biomedical Applications of Cerium Oxide Nanoparticles Changes in cardiopulmonary function induced by nanoparticles Cerium Dioxide Nanoparticle Exposure Improves Microvascular Dysfunction and Reduces Oxidative Stress in Spontaneously Hypertensive Rats Shifts in oxidation states of cerium oxide nanoparticles detected inside intact hydrated cells and organelles Cerium dioxide nanoparticles do not modulate the lipopolysaccharide-induced inflammatory response in human monocytes Comparison of the cytotoxic potential of cigarette smoke and electronic cigarette vapour extract on cultured myocardial cells.On The Protection by The Combination of CeO2 Nanoparticles and Sodium Selenite on Human Lymphocytes against Chlorpyrifos-Induced Apoptosis In Vitro Real-time monitoring of superoxide accumulation and antioxidant activity in a brain slice model using an electrochemical cytochrome c biosensor.Preparation and Characterization Challenges to Understanding Environmental and Biological Impacts of Nanoparticles.Protection from cigarette smoke-induced vascular injury by recombinant human relaxin-2 (serelaxin)Persistent alterations of gene expression profiling of human peripheral blood mononuclear cells from smokers Cellular interaction and toxicity depend on physicochemical properties and surface modification of redox-active nanomaterials.Cationic lipid-nanoceria hybrids, a novel nonviral vector-mediated gene delivery into mammalian cells: investigation of the cellular uptake mechanism.Antioxidation of Cerium Oxide Nanoparticles to Several Series of Oxidative Damage Related to Type II Diabetes Mellitus In Vitro Cerium Oxide Nanoparticles in Lung Acutely Induce Oxidative Stress, Inflammation, and DNA Damage in Various Organs of Mice Cerium oxide nanoparticles: applications and prospects in nanomedicine.Effect of cerium oxide nanoparticles on sepsis induced mortality and NF-κB signaling in cultured macrophages.Mitochondria and neurodegenerative diseases: the promising role of nanotechnology in targeted drug delivery.Antioxidant and anti-genotoxic properties of cerium oxide nanoparticles in a pulmonary-like cell system.Viability and gene expression responses to polymeric nanoparticles in human and rat cells.Cerium oxide nanoparticles protect endothelial cells from apoptosis induced by oxidative stress.Effects of cerium oxide nanoparticles on PC12 neuronal-like cells: proliferation, differentiation, and dopamine secretion.Assessment of the toxic potential of engineered metal oxide nanomaterials using an acellular model: citrated rat blood plasma.A role of ZnO nanoparticle electrostatic properties in cancer cell cytotoxicity.Cerium oxide nanoparticle aggregates affect stress response and function in Caenorhabditis elegans.Preparation, Characterization, and Preliminary In Vitro Testing of Nanoceria-Loaded Liposomes.Increased 8-hydroxy-2'-deoxyguanosine in leukocyte DNA from patients with type 2 diabetes and microangiopathy.Distribution, elimination, and biopersistence to 90 days of a systemically introduced 30 nm ceria-engineered nanomaterial in rats.Natural Antioxidants as Potential Therapy, and a Promising Role for Melatonin Against Pulmonary Hypertension.Cerium oxide nanoparticles: the regenerative redox machine in bioenergetic imbalance.Rat hippocampal responses up to 90 days after a single nanoceria dose extends a hierarchical oxidative stress model for nanoparticle toxicity.Antioxidant and antigenotoxic properties of CeO2 NPs and cerium sulphate: Studies with Drosophila melanogaster as a promising in vivo model.Cerium oxide nanoparticles inhibit adipogenesis in rat mesenchymal stem cells: potential therapeutic implications.Cerium oxide nanoparticles prevent apoptosis in primary cortical culture by stabilizing mitochondrial membrane potential.Surface Functionalization of Iron Oxide Nanoparticles with Gallic Acid as Potential Antioxidant and Antimicrobial Agents.Comparative evaluation of intestinal nitric oxide in embryonic zebrafish exposed to metal oxide nanoparticles.

P2860

Q23917498-12807808-C3CF-4978-95DD-C4CAD80EFBEB Q23920228-825EE2E2-C9E4-4DC5-8C18-D38CBA2B792E Q23923217-EEEF6CD6-3B2E-4B5F-B7D8-C890D3FD48CB Q26747643-8F9343E1-A2EB-439C-BE86-880DACA29461 Q28383937-B3805FF4-2A28-4F18-82FE-43146AE5A3B0 Q28389900-90705817-86DE-480E-A33D-2F043F7CA13E Q28393957-001F59CC-3396-48D0-BE83-D376D13EB4AD Q28396653-342D1789-209F-4415-99C7-9B78B0A242EA Q28397788-70F7FC86-3DDE-489F-A612-1A267381CAEF Q34378386-F1FA72FD-3691-4411-AC5E-566BCA4B2B99 Q35856061-85934EEA-930A-4549-B2B4-C2B251CCE314 Q36589168-5A2CF530-8D3B-4249-8E03-6E8A4D0FF5C9 Q36617879-4A644309-2E11-41B6-8B50-C33BCA35C017 Q36797528-54E547B4-AA85-487D-A525-FBD9E65D582B Q36880480-C5B89923-5DF3-4DBC-8C48-AF2F6E6DD943 Q36979177-5A7E050A-E36E-46BA-8D1F-E720628C4780 Q37067695-B0D9397D-243E-4087-BADC-C0920C621E9A Q37368317-5C4F7079-345B-419F-82FB-5C0CC1231537 Q37723684-C2F5397D-B8B5-4E98-9263-859C83DCE046 Q38132412-C590DA1F-D8FF-4EFD-B111-1E5D75768A9B Q38877696-41598736-C0B0-4F5F-AFE1-BDA6F3CF98CF Q38910964-B134F3B1-0343-4888-A0E1-ADBB113725A1 Q38916782-480328AA-7D45-471E-8F11-B35612055D3C Q39002679-097CDDA4-73AA-4FA6-A020-5307E5AB4825 Q39143475-F070AE3C-BFC1-4E02-BBE4-435AE38F22BB Q39154004-A69EE007-5A92-4904-BF1B-692EF56E651D Q39454679-6B48A6B7-C8F4-4A2E-9EA3-8ADF4A2C871E Q39530361-00300906-833B-43D2-AFE9-0C780C615E15 Q40104391-986C90C4-A292-4C1B-83D5-9E2A78DB395A Q41666902-3C0548AC-ACDC-42B6-9D16-8C67FCEDCF3D Q41958021-44E9E959-6D4A-4BDD-8550-35633E774F6B Q42720973-5F5FE691-6C34-4376-9A34-FA2B7DAF7FE1 Q46183692-DD4FC7DB-9F09-4AD5-83F8-B1B8B9668034 Q46442323-7A10A898-9A9C-4F58-A44E-1CFA89206E67 Q46567213-A70CA1E8-E39D-4506-BFB0-0E077FBA1CA6 Q46819740-36518996-BEBF-4864-B82C-497CCF3B6DC9 Q46896831-9783AAAA-76C2-452D-BAEE-C22FE54704B5 Q46916516-D9105EF2-698A-465F-ADC1-4F4B5DEA3709 Q47163288-15865BFD-BE5B-4984-BCBB-0E0E99EA6387 Q50732854-90B49AF6-59D0-4F2B-9D08-72A518B75663

P2860

Cerium oxide nanoparticles inhibit oxidative stress and nuclear factor-κB activation in H9c2 cardiomyocytes exposed to cigarette smoke extract.

http://www.wikidata.org/entity/Q35077951

description

2011 nî lūn-bûn

@nan

2011 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Cerium oxide nanoparticles inh ...... ed to cigarette smoke extract.

@ast

Cerium oxide nanoparticles inh ...... ed to cigarette smoke extract.

@en

type

label

Cerium oxide nanoparticles inh ...... ed to cigarette smoke extract.

@ast

Cerium oxide nanoparticles inh ...... ed to cigarette smoke extract.

@en

prefLabel

Cerium oxide nanoparticles inh ...... ed to cigarette smoke extract.

@ast

Cerium oxide nanoparticles inh ...... ed to cigarette smoke extract.

@en

P1433

Q35077951-7EDB501E-BFB2-421A-84A9-D6C17406A013

P1476

Q35077951-2013933A-9804-4AE1-9EA6-148A042911FB

P2093

Q35077951-112E9A14-CF51-439D-9622-A55AA073BF19

Q35077951-EA21A48F-1ABB-4304-8591-CC0D8334D20D

Q35077951-FD5AD7EA-9285-46D8-AEA5-BD948FC954EE

P2860

Q35077951-021AF12A-FF3A-4044-9EE1-4B39251022A3

Q35077951-10C09978-C16B-4CC5-8C31-6809315A45EF

Q35077951-1D254BF5-D879-49F9-81FA-079227B6EE9C

Q35077951-31CCD1EA-C379-4958-86DB-31FEB04A65F5

Q35077951-31D07433-3331-43F0-83E2-23A9337363F1

Q35077951-3DD4353D-02CB-4AD3-AD24-27B98A5A121F

Q35077951-4D952041-FFF9-4AD5-9F0B-CD08B5DBD20C

Q35077951-673596D0-06BF-4E33-B887-D94BD23144AC

Q35077951-68DEAA54-AA2D-4A4C-BCD2-25B18BC2EF4C

Q35077951-6BF9FF7A-E32E-47C3-AE37-9B59C3152E29

P304

Q35077951-757F1424-6C66-45D8-AAD8-6D6BCFD21230

P31

Q35077951-5B03B952-17FB-4893-8CC1-58D522EBF282

P356

Q35077951-535A4A0A-51C5-45F1-9F8A-2DD15292A765

P407

Q35077951-D83D97A3-F91F-4AFF-99FB-167E65A86AF8

P433

Q35077951-C4DBD0A2-9B37-494B-860B-A749FDF99215

P478

Q35077951-AC15D146-8C39-4FD2-8124-E75400FAB707

P577

Q35077951-B0DA334D-712C-41EC-BFFD-003F056E0B44

P5875

Q35077951-997088A9-E2B3-41C5-8AA1-843780615BDE

P698

Q35077951-F3360A17-B441-49A6-B701-FBDA38EA6163

P921

Q35077951-04317463-758F-43C8-B190-F225EF3F86B7

P932

Q35077951-F091D9E6-E7B5-45B7-9C28-8414F5FBC80B

P356

JPET.111.179978

P1433

Journal of Pharmacology and Experimental Therapeutics

P1476

Cerium oxide nanoparticles inh ...... ed to cigarette smoke extract.

@en

P2093

Jianli Niu

http://www.w3.org/2001/XMLSchema#string

Kangkai Wang

http://www.w3.org/2001/XMLSchema#string

Pappachan E Kolattukudy

http://www.w3.org/2001/XMLSchema#string

P2860

Caspase-3-generated fragment of gelsolin: effector of morphological change in apoptosis

Cardiac-targeted expression of soluble fas attenuates doxorubicin-induced cardiotoxicity in mice

Cigarette smoke extract induces oxidative stress and apoptosis in human lung fibroblasts.

Environmental tobacco smoke and ischemic heart disease.

The pathophysiology of cigarette smoking and cardiovascular disease: an update.

Cardioprotective effects of cerium oxide nanoparticles in a transgenic murine model of cardiomyopathy.

Transcription factor NF-kappaB: a sensor for smoke and stress signals.

Regulating the regulator: NF-kappaB signaling in heart.

Smoking, oxidative stress and cardiovascular diseases--do anti-oxidative therapies fail?

Radical nanomedicine.

P304

53-61

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1124/JPET.111.179978

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

338

http://www.w3.org/2001/XMLSchema#string

P577

2011-04-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

50999597

http://www.w3.org/2001/XMLSchema#string

P698

21464334

http://www.w3.org/2001/XMLSchema#string

P921

P932

3126650

http://www.w3.org/2001/XMLSchema#string